- Home
- BIRD vs PMVP Comparison
BIRD vs PMVP Comparison
Compare BIRD & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRD
- PMVP
- Stock Information
- Founded
- BIRD 2015
- PMVP 2013
- Country
- BIRD United States
- PMVP United States
- Employees
- BIRD N/A
- PMVP N/A
- Industry
- BIRD Apparel
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- BIRD Consumer Discretionary
- PMVP Health Care
- Exchange
- BIRD Nasdaq
- PMVP Nasdaq
- Market Cap
- BIRD 89.7M
- PMVP 77.4M
- IPO Year
- BIRD 2021
- PMVP 2020
- Fundamental
- Price
- BIRD $6.13
- PMVP $1.23
- Analyst Decision
- BIRD Buy
- PMVP Strong Buy
- Analyst Count
- BIRD 2
- PMVP 1
- Target Price
- BIRD $11.00
- PMVP $5.00
- AVG Volume (30 Days)
- BIRD 49.9K
- PMVP 2.5M
- Earning Date
- BIRD 11-05-2025
- PMVP 11-06-2025
- Dividend Yield
- BIRD N/A
- PMVP N/A
- EPS Growth
- BIRD N/A
- PMVP N/A
- EPS
- BIRD N/A
- PMVP N/A
- Revenue
- BIRD $170,646,000.00
- PMVP N/A
- Revenue This Year
- BIRD N/A
- PMVP N/A
- Revenue Next Year
- BIRD $4.20
- PMVP N/A
- P/E Ratio
- BIRD N/A
- PMVP N/A
- Revenue Growth
- BIRD N/A
- PMVP N/A
- 52 Week Low
- BIRD $3.93
- PMVP $0.81
- 52 Week High
- BIRD $14.20
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- BIRD 36.32
- PMVP 39.98
- Support Level
- BIRD $5.93
- PMVP $1.19
- Resistance Level
- BIRD $6.32
- PMVP $1.84
- Average True Range (ATR)
- BIRD 0.34
- PMVP 0.16
- MACD
- BIRD 0.09
- PMVP -0.03
- Stochastic Oscillator
- BIRD 18.18
- PMVP 6.15
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.